文献速递腹部MR

0.55 T MRI评估胰腺导管内乳头状黏液性肿瘤:与1.5 T和3 T MRI的个体内比较

MRI at 0.55 T for Assessment of Pancreatic Intraductal Papillary Mucinous Neoplasms: An Intraindividual Comparison Versus 1.5-T and 3-T MRI.
PubMed 文献 · AJR Am J Roentgenol · 2025-12-10

这项回顾性研究纳入35例胰腺导管内乳头状黏液性肿瘤患者,比较0.55 T与1.5/3 T MRI对囊肿特征、图像质量和诊断信心的评估。两种场强间对可疑囊肿特征的一致性为优秀到极好,0.55 T图像质量和诊断信心较低但所有检查均具诊断性。

要点

  • 0.55 T与1.5/3 T MRI对IPMN类型、胰管扩张、囊肿大小、胰管直径及全部5项可疑囊肿特征的一致性为优秀到极好。
  • 0.55 T的平均图像质量(7.5±1.7)和诊断信心(8.0±1.7)低于1.5/3 T(分别为8.6±1.3和8.7±1.3),差异有统计学意义(p<.001)。
  • 所有0.55 T和1.5/3 T检查均被所有阅片者认为具诊断性(诊断信心≥5)。

核心结论

  • 两种场强对可疑囊肿特征的一致性均为优秀,所有0.55 T检查均被认为具诊断性。

研究设计与样本

  • 回顾性研究纳入35例胰腺IPMN患者(中位年龄70岁,女25例、男10例),均接受0.55 T(2022年4月8日至2023年11月15日)和1.5/3 T腹部MRI,间隔13个月内;7名放射科医生独立阅片评估囊肿特征、图像质量和诊断信心(1-10分,10分最高)。

关键影像表现/征象

  • 0.55 T与1.5/3 T MRI对IPMN类型的一致性极好(Gwet AC1=0.87),对胰管扩张的一致性极好(Gwet AC1=0.94)。
  • 囊肿大小的一致性极好(ICC=0.96),胰管直径的一致性极好(ICC=0.99)。
  • 全部5项可疑囊肿特征(强化壁结节<5 mm、强化壁结节≥5 mm、增厚强化壁/分隔、胰管口径突然改变伴上游萎缩、胰周淋巴结增大)的一致性极好(Gwet AC1=0.88-0.99)。
  • 多灶性的一致性为相当好(Gwet AC1=0.62),囊肿位置的一致性为中等(Gwet AC1=0.55)。

诊断标准与关键数值

  • 0.55 T与1.5/3 T MRI对IPMN类型的一致性极好(Gwet AC1=0.87),对胰管扩张的一致性极好(Gwet AC1=0.94)。
  • 囊肿大小的一致性极好(ICC=0.96),胰管直径的一致性极好(ICC=0.99)。
  • 全部5项可疑囊肿特征的一致性极好(Gwet AC1=0.88-0.99),多灶性一致性相当好(Gwet AC1=0.62),囊肿位置一致性中等(Gwet AC1=0.55)。

临床应用与阅片要点

  • 0.55 T MRI平均图像质量7.5±1.7低于1.5/3 T的8.6±1.3(p<.001),平均诊断信心8.0±1.7低于1.5/3 T的8.7±1.3(p<.001)。
  • 所有0.55 T和1.5/3 T检查均被所有阅片者认为具诊断性(诊断信心≥5)。
  • 1例患者发生IPMN相关恶性肿瘤,对应1名阅片者识别的5 mm强化壁结节,该阅片者在两种场强下均识别出该征象。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Mid-field (0.55-T) MRI may offer an alternative to MRI performed at higher field strengths for surveillance of pancreatic intraductal papillary mucinous neoplasms (IPMNs), given the high-quality MRCP sequences enabled by longer T2 relaxation times and the greater patient comfort resulting from a larger bore and reduced acoustic noise. However, the SNR is lower at 0.55 T. OBJECTIVE. The objective of this study was to compare the assessment of pancreatic IPMNs by MRI performed at 0.55 T versus MRI conducted at higher field strengths in terms of cyst feature characterization, image quality, and diagnostic confidence. METHODS. This retrospective study included 35 patients (median age, 70 years; 25 women and 10 men) with a pancreatic IPMN who underwent abdominal MRI performed both at 0.55 T (conducted between April 8, 2022, and November 15, 2023) and at 1.5 or 3 T (hereafter, 1.5/3 T) within a 13-month interval. Seven radiologists independently reviewed the examinations to identify cyst characteristics as well as to determine image quality and diagnostic confidence (using scales of 1-10, with 10 denoting the highest score). RESULTS. Across readers, agreement between 0.55-T and 1.5/3-T MRI examinations was excellent for IPMN type (Gwet agreement coefficient 1 [Gwet AC1], 0.87), presence of pancreatic duct dilatation (Gwet AC1, 0.94), cyst size (intraclass correlation coefficient [ICC], 0.96), diameter of pancreatic duct (ICC, 0.99), and all five suspicious cyst features that were assessed (enhancing mural nodule < 5 mm, enhancing mural nodule ≥ 5 mm, thickened enhancing walls/septa, abrupt change in pancreatic duct caliber with upstream atrophy, and enlarged peripancreatic lymph nodes; Gwet AC1, 0.88-0.99), and it was substantial for multifocality (Gwet AC1, 0.62) and moderate for cyst location (Gwet AC1, 0.55). Across readers, 0.55-T examinations, compared with 1.5/3-T examinations, showed lower mean image quality (7.5 ± 1.7 [SD] vs 8.6 ± 1.3, p < .001) and lower mean diagnostic confidence (8.0 ± 1.7 [SD] vs 8.7 ± 1.3; p < .001). However, all 0.55-T and 1.5/3-T examinations were considered diagnostic (diagnostic confidence ≥ 5) by all readers. One patient developed IPMN-related malignancy, which corresponded to a 5-mm enhancing mural nodule identified by one reader, who identified this finding at both field strengths. CONCLUSION. Agreement for suspicious cyst features was excellent at both field strengths. All 0.55-T examinations were considered diagnostic. CLINICAL IMPACT. The findings may help guide the application of 0.55-T MRI in the longitudinal surveillance of pancreatic IPMNs and inform relevant technical improvement efforts.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Rajeev R, Gulani V, Mendiratta-Lala M, et al. MRI at 0.55 T for Assessment of Pancreatic Intraductal Papillary Mucinous Neoplasms: An Intraindividual Comparison Versus 1.5-T and 3-T MRI. AJR Am J Roentgenol. 2025. PMID: 40928167. doi:10.2214/AJR.25.33252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。